Gaeta Therapeutics
Pre-clinicalGaeta Therapeutics was founded by the University of Zurich in 2017 as a vehicle for the commercialisation of its immuno-oncology patent estate, relating to the use of Interleukin-12 (IL-12) in combination with checkpoint blockers in the treatment of cancer.
Founded
2017
Focus
Cell TherapyRegenerative Medicine
About
Gaeta Therapeutics was founded by the University of Zurich in 2017 as a vehicle for the commercialisation of its immuno-oncology patent estate, relating to the use of Interleukin-12 (IL-12) in combination with checkpoint blockers in the treatment of cancer.
Company Info
TypePrivate
Founded2017
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile